Feb 14, 2013:
iCo Therapeutics Ranked Number One in Technology & Life Sciences on 2013 TSX Venture 50

Feb 5, 2013:
iCo Therapeutics to Present at the 15th Annual BIO CEO & Investor Conference

Jan 22, 2013:
iCo Therapeutics Grants Options to Directors, Officers and Employees

Jan 3, 2013:
iCo Therapeutics Announces Positive iCo-007 Phase 2 Clinical Update